- Home
- APWC vs GDTC Comparison
APWC vs GDTC Comparison
Compare APWC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- GDTC
- Stock Information
- Founded
- APWC 1996
- GDTC 2018
- Country
- APWC Taiwan
- GDTC Singapore
- Employees
- APWC N/A
- GDTC N/A
- Industry
- APWC Telecommunications Equipment
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- GDTC Health Care
- Exchange
- APWC Nasdaq
- GDTC Nasdaq
- Market Cap
- APWC 30.1M
- GDTC 29.4M
- IPO Year
- APWC 1997
- GDTC 2023
- Fundamental
- Price
- APWC $1.50
- GDTC $2.40
- Analyst Decision
- APWC
- GDTC Buy
- Analyst Count
- APWC 0
- GDTC 1
- Target Price
- APWC N/A
- GDTC $5.00
- AVG Volume (30 Days)
- APWC 4.1K
- GDTC 15.9K
- Earning Date
- APWC 03-31-2025
- GDTC 01-01-0001
- Dividend Yield
- APWC N/A
- GDTC N/A
- EPS Growth
- APWC N/A
- GDTC N/A
- EPS
- APWC 0.17
- GDTC N/A
- Revenue
- APWC $472,672,000.00
- GDTC $330,254.00
- Revenue This Year
- APWC N/A
- GDTC $14.71
- Revenue Next Year
- APWC N/A
- GDTC N/A
- P/E Ratio
- APWC $8.94
- GDTC N/A
- Revenue Growth
- APWC 11.02
- GDTC N/A
- 52 Week Low
- APWC $1.24
- GDTC $1.20
- 52 Week High
- APWC $2.02
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- APWC 45.43
- GDTC 44.76
- Support Level
- APWC $1.46
- GDTC $1.98
- Resistance Level
- APWC $1.59
- GDTC $2.56
- Average True Range (ATR)
- APWC 0.04
- GDTC 0.18
- MACD
- APWC -0.00
- GDTC -0.03
- Stochastic Oscillator
- APWC 20.59
- GDTC 51.04
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.